Heart Disease, Cancer, Diabetes, and Other Chronic Diseases
Chronic diseases such as heart disease, cancer, and diabetes are the leading causes of death and disability in the United States. They are also leading drivers of the nation's $4.5 trillion in annual health care costs.
A JAMA study published yesterday found that more adults age 45-49 have been diagnosed with colorectal cancer, a finding that coincides with recommendations by the American Cancer Society in 2018 and the United States Preventive Services Task Force in 2021 to lower the screening age from 50 to 45.
A study published June 25 by the Journal of the American Heart Association found that heart disease death rates fell 66% from 1970 to 2022.
The opening in May 2025 of New Jersey's first freestanding cancer hospital, the Jack & Sheryl Morris Cancer Center, brings renewed hope for cancer patients and their families.
The University of Arkansas for Medical Sciences is working to enhance their cancer treatment research with a nearly $3 million grant from the National Institutes of Health.
The White House May 22 released its Make America Healthy Again report that focuses on childhood chronic disease. The report highlights findings from the MAHA Commission related to poor diet, exposure to environmental chemicals, lack of physical activity, stress and overmedicalization.
Traditional chemotherapy is delivered via the bloodstream, making it less effective for metastatic cancers that occur within the peritoneal cavity — such as colorectal, appendiceal, gastric, ovarian and others. Pressurized intraperitoneal aerosolized chemotherapy offers new hope for patients with…
Researchers at Mass General Brigham have developed a deep learning algorithm called FaceAge that uses a photo of a person’s face to predict biological age and survival outcomes for cancer patients.
Ascension Saint Thomas health system in Tennessee has entered into a strategic joint venture with PathPoint Health, a provider of metabolic care, to help people prevent and manage obesity, diabetes, or prediabetes.
The National Institutes of Health May 8 released an analysis that found incidences of 14 types of cancer increased among people under age 50 from 2010-2019.
A New England Journal of Medicine study published April 27 found success in administering dostarlimab, an immunotherapy drug, to a group of 103 cancer patients instead of traditional methods such as chemotherapy, radiation or surgery.